Table 2: Localization of first clinical recurrence/tumor progression in the 26 study patients with stage I to III primary carcinosarcoma of the ovary.

	No. of patients (%)
Pelvis	8 (31%)
Liver	6 (23%)
Peritoneum	5 (19%)
Liver and pelvis	2 (8%)
Liver and peritoneum	1 (4%)
Paraaortic	1 (4%)
Peritoneum and pelvis	1 (4%)
Adrenal gland	1 (4%)